Candelanza, Jessa Mae G.

HRN: 21-72-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
AMPICILLIN 250MG (VIAL)
08/16/2022
08/23/2022
IVT
160mg
Q12
PSNB Sec To Thickly Msaf
Waiting Final Action 
08/16/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
08/16/2022
08/23/2022
IVT
16mg
Q24
PsNB Sec To Thickly MSAF
Waiting Final Action 
06/28/2023
CEFTRIAXONE 1G (VIAL)
06/28/2023
07/04/2023
IVT
365mg
Q12
Pneumonia, UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: